Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerHomayoun Zargar, Peter C. Black, Srikala S. Sridhar et al.|European Urology|2014Cited by 297
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J. Black, Peter C. Black, Homayoun Zargar et al.|Urologic Oncology Seminars and Original Investigations|2019Cited by 44
Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International ConsortiumMaria Carmen Mir, Peter C. Black, Michele Marchioni et al.|European Urology Focus|2020Cited by 34
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerDavid D‘Andrea, Shahrokh F. Shariat, Peter C. Black et al.|Urologic Oncology Seminars and Original Investigations|2020Cited by 23
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinomaDavid D‘Andrea, Shahrokh F. Shariat, Surena F. Matin et al.|British Journal of Urology|2020Cited by 16